gastroesophageal-reflux-disease

Documents about gastroesophageal-reflux-disease

• RELIEF Europe Study#889727ClinicalTrials.gov
• Treatment Use of Domperidone for Gastroparesis#902328ClinicalTrials.gov
• Machine learning for screening laryngopharyngeal reflux symptoms in college students: a cross-sectional study#5179Europe PMC
• Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use#889524ClinicalTrials.gov
• Which drugs are risk factors for the development of gastroesophageal reflux disease?#954937Koc University Digital Collections
• Structure and Function of the Gastro-esophageal Junction#842834ClinicalTrials.gov
• National Survey on GERD Patients (Adults and Children)#859302ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks#857930ClinicalTrials.gov
• Impact of meal frequency on gastroesophageal reflux disease following laparoscopic sleeve gastrectomy.#330950NCBI PubMed Central
• Causal effect of gastroesophageal reflux disease on cataracts: A mendelian randomization study.#613512NCBI PubMed Central
• Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients#841750ClinicalTrials.gov
• National Survey on Gastroesophageal Reflux Disease (GERD) Patients#899307ClinicalTrials.gov
• Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn#905458ClinicalTrials.gov
• Is it Barrett's esophagus or gastric heterotopia?#934689Koc University Digital Collections
• Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease#843377ClinicalTrials.gov
• Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study#981101ClinicalTrials.gov
• Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study#915252ClinicalTrials.gov
• ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia#826534ClinicalTrials.gov
• Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease)#887943ClinicalTrials.gov
• Endoscopy-related Phone Consultation During the COVID-19 Outbreak#894325ClinicalTrials.gov
• Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets#910715ClinicalTrials.gov
• Do Acid Sensing Ion Channels Contribute to Heartburn?#995232ClinicalTrials.gov
• The EndoGastric Solutions TEMPO Trial#840276ClinicalTrials.gov
• Examining Social Determinants and Lifestyle Factors in Persons with Interstitial Lung Diseases and Gastroesophageal Reflux Disease#309826Scholar Commons
• A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab#827935ClinicalTrials.gov
• Validation of HRM Score for the GERD Diagnosis#807685ClinicalTrials.gov
• Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease#892341ClinicalTrials.gov
• Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)#857661ClinicalTrials.gov
• The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker#908592ClinicalTrials.gov
• Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)#810803ClinicalTrials.gov
• The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43#874058ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease#907108ClinicalTrials.gov
• Relationships Among Type D Personality, Symptoms, Depression and Anxiety, and Quality of Life in Patients With Gastroesophageal Reflux Disease.#449761NCBI PubMed Central
• Implementing Virtual Reality (VR) to Reduce Sedation#828633ClinicalTrials.gov
• Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer#981341ClinicalTrials.gov
• Dynamic precision therapy in chronic gastrointestinal diseases: A focus on gastroesophageal reflux disease and inflammatory bowel disease—A narrative review and conceptual perspective.#615862NCBI PubMed Central
• Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.#831305ClinicalTrials.gov
• Zuojin Wan Combined With Woonosan Fumarate for the Treatment of GRD Combined With Depression#908051ClinicalTrials.gov
• Prescription Methods Assessment Project (PMAP)#877794ClinicalTrials.gov
• The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients#889810ClinicalTrials.gov
• A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg#966094ClinicalTrials.gov
• Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France#874269ClinicalTrials.gov
• Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.#900733ClinicalTrials.gov
• Effect of Long-Term Electrical Stimulation on LES Pressure and Esophageal Acid Exposure in Patients With GERD#803784ClinicalTrials.gov
• Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets#896755ClinicalTrials.gov
• Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.#827958ClinicalTrials.gov
• Effect of Continuous Positive Airway Pressure (CPAP) on Lower Esophageal Sphincter Pressure in Morbidly Obese Patients#852223ClinicalTrials.gov
• Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B#880504ClinicalTrials.gov
• Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD#850474ClinicalTrials.gov
• Impact of Crural Repair and Gastropexy During Laparoscopic Sleeve Gastrectomy#837785ClinicalTrials.gov